• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于组织工程支架构建血管移植物。

Construction of vascular grafts based on tissue-engineered scaffolds.

作者信息

Lang Zhongliang, Chen Tianao, Zhu Shilu, Wu Xizhi, Wu Yongqi, Miao Xiaoping, Wang Qiang, Zhao Liping, Zhu Zhiqiang, Xu Ronald X

机构信息

Department of Plastic Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230001, PR China.

School of Biomedical Engineering, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, 230026, PR China.

出版信息

Mater Today Bio. 2024 Nov 10;29:101336. doi: 10.1016/j.mtbio.2024.101336. eCollection 2024 Dec.

DOI:10.1016/j.mtbio.2024.101336
PMID:39624049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11609327/
Abstract

Cardiovascular disease (CVD) ranks among the leading causes of morbidity and mortality globally, primarily due to arterial occlusive disease. Vascular bypass remains the cornerstone of treatment; however, many patients lack suitable autologous vessels (e.g., saphenous vein) for grafting. Tissue-engineered vascular grafts (TEVGs) provide a viable alternative capable of integrating, remodeling, and repairing host vessels, responding to mechanical and biochemical stimuli. Currently, preparation methods for TEVGs are mainly categorized into scaffold-free and scaffold-based approaches. Scaffold-free methods exhibit comparatively weaker mechanical properties and limited research progress, whereas scaffold-based approaches show more promising applications due to their superior mechanical properties and biocompatibility. This review examines current research progress in materials, fabrication processes, functionalized modifications, cell implantation, and animal and clinical experiments for scaffold-based preparation of TEVGs. By exploring current challenges and future perspectives in this field, we expect to provide new insights into TEVGs development and expedite their clinical applications.

摘要

心血管疾病(CVD)是全球发病和死亡的主要原因之一,主要归因于动脉闭塞性疾病。血管搭桥术仍然是治疗的基石;然而,许多患者缺乏适合移植的自体血管(如大隐静脉)。组织工程血管移植物(TEVG)提供了一种可行的替代方案,能够整合、重塑和修复宿主血管,对机械和生化刺激做出反应。目前,TEVG的制备方法主要分为无支架和有支架两种途径。无支架方法的机械性能相对较弱,研究进展有限,而有支架方法由于其优越的机械性能和生物相容性,显示出更有前景的应用。本文综述了基于支架制备TEVG在材料、制造工艺、功能化修饰、细胞植入以及动物和临床试验方面的研究进展。通过探讨该领域当前的挑战和未来前景,我们期望为TEVG的发展提供新的见解,并加速其临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/3b06624d4f9a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/97b8d3a92c5c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/19f6d2360fad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/5d5591b4ca1b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/a736a9732aad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/86f9a73f1975/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/47da6e250faa/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/b44e37f3fbd5/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/3b06624d4f9a/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/97b8d3a92c5c/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/19f6d2360fad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/5d5591b4ca1b/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/a736a9732aad/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/86f9a73f1975/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/47da6e250faa/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/b44e37f3fbd5/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c82a/11609327/3b06624d4f9a/gr7.jpg

相似文献

1
Construction of vascular grafts based on tissue-engineered scaffolds.基于组织工程支架构建血管移植物。
Mater Today Bio. 2024 Nov 10;29:101336. doi: 10.1016/j.mtbio.2024.101336. eCollection 2024 Dec.
2
Tissue engineered small-diameter vascular grafts.组织工程化小口径血管移植物
Clin Plast Surg. 2003 Oct;30(4):507-17. doi: 10.1016/s0094-1298(03)00069-5.
3
Biofabrication of small diameter tissue-engineered vascular grafts.组织工程小口径血管移植物的生物制造。
Acta Biomater. 2022 Jan 15;138:92-111. doi: 10.1016/j.actbio.2021.11.012. Epub 2021 Nov 13.
4
Bioresorbable silk grafts for small diameter vascular tissue engineering applications: In vitro and in vivo functional analysis.生物可吸收丝移植物在小直径血管组织工程应用中的体外和体内功能分析。
Acta Biomater. 2020 Mar 15;105:146-158. doi: 10.1016/j.actbio.2020.01.020. Epub 2020 Jan 17.
5
Translational tissue-engineered vascular grafts: From bench to bedside.翻译组织工程血管移植物:从实验室到临床。
Biomaterials. 2023 Nov;302:122322. doi: 10.1016/j.biomaterials.2023.122322. Epub 2023 Sep 11.
6
Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.基于无细胞纳米纤维聚己内酯/壳聚糖支架构建的组织工程小口径动脉血管移植物在绵羊模型中的研究
PLoS One. 2016 Jul 28;11(7):e0158555. doi: 10.1371/journal.pone.0158555. eCollection 2016.
7
Tissue Engineering: A Coupled Agent-Based Finite Element Approach.组织工程学:基于耦合代理的有限元方法。
Tissue Eng Part C Methods. 2019 Nov;25(11):641-654. doi: 10.1089/ten.TEC.2019.0103. Epub 2019 Sep 20.
8
Challenges and Possibilities of Cell-Based Tissue-Engineered Vascular Grafts.基于细胞的组织工程血管移植物的挑战与机遇
Cyborg Bionic Syst. 2021 Feb 18;2021:1532103. doi: 10.34133/2021/1532103. eCollection 2021.
9
Current Progress in Vascular Engineering and Its Clinical Applications.血管工程学的当前进展及其临床应用。
Cells. 2022 Jan 31;11(3):493. doi: 10.3390/cells11030493.
10
Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis.单细胞 RNA 测序分析植入组织工程化血管移植物细胞的分离。
Tissue Eng Part C Methods. 2023 Feb;29(2):72-84. doi: 10.1089/ten.TEC.2022.0189.

引用本文的文献

1
Fabrication and characterization of electrospun polycaprolactone/ derived-ECM composite scaffolds for small-diameter vascular grafts.用于小口径血管移植物的电纺聚己内酯/衍生细胞外基质复合支架的制备与表征
RSC Adv. 2025 Aug 29;15(38):31060-31075. doi: 10.1039/d5ra04406e.
2
Influence of Scaffold Structure and Biomimetic Properties on Adipose Stem Cell Homing in Personalized Reconstructive Medicine.支架结构和仿生特性对个性化重建医学中脂肪干细胞归巢的影响。
Biomimetics (Basel). 2025 Jul 3;10(7):438. doi: 10.3390/biomimetics10070438.
3
Substrate Stiffness Modulates TGF-β1-Induced Lineage Specification in Multipotent Vascular Stem Cells.

本文引用的文献

1
Glutamine synthetase accelerates re-endothelialization of vascular grafts by mitigating endothelial cell dysfunction in a rat model.谷氨酰胺合成酶通过减轻大鼠模型内皮细胞功能障碍加速血管移植物的再内皮化。
Biomaterials. 2025 Mar;314:122877. doi: 10.1016/j.biomaterials.2024.122877. Epub 2024 Oct 5.
2
Suspension electrospinning of decellularized extracellular matrix: A new method to preserve bioactivity.脱细胞细胞外基质的悬浮静电纺丝:一种保留生物活性的新方法。
Bioact Mater. 2024 Aug 28;41:640-656. doi: 10.1016/j.bioactmat.2024.08.012. eCollection 2024 Nov.
3
Developing fibrin-based biomaterials/scaffolds in tissue engineering.
底物刚度调节多能血管干细胞中转化生长因子-β1诱导的谱系定向分化。
Cells. 2025 Apr 17;14(8):611. doi: 10.3390/cells14080611.
在组织工程中开发基于纤维蛋白的生物材料/支架。
Bioact Mater. 2024 Aug 15;40:597-623. doi: 10.1016/j.bioactmat.2024.08.006. eCollection 2024 Oct.
4
3D-Printed Hydrogels with Engineered Nanocrystalline Domains as Functional Vascular Constructs.3D 打印具有工程纳米晶域的水凝胶作为功能性血管构建体。
ACS Nano. 2024 Sep 17;18(37):25765-25777. doi: 10.1021/acsnano.4c08359. Epub 2024 Sep 4.
5
Fabrication of small-diameter in situ tissue engineered vascular grafts with core/shell fibrous structure and a one-year evaluation via rat abdominal vessel replacement model.采用核壳纤维结构原位构建小直径组织工程血管移植物及其在大鼠腹主动脉置换模型中的一年评估。
Biomater Adv. 2024 Dec;165:214018. doi: 10.1016/j.bioadv.2024.214018. Epub 2024 Aug 31.
6
Tailored endothelialization enabled by engineered endothelial cell vesicles accelerates remodeling of small-diameter vascular grafts.工程化内皮细胞囊泡实现的定制内皮化可加速小口径血管移植物的重塑。
Bioact Mater. 2024 Jul 17;41:127-136. doi: 10.1016/j.bioactmat.2024.07.006. eCollection 2024 Nov.
7
Design and fabrication of dual-layer PCL nanofibrous scaffolds with inductive influence on vascular cell responses.设计并制作具有诱导血管细胞响应双层 PCL 纳米纤维支架。
Colloids Surf B Biointerfaces. 2024 Aug;240:113988. doi: 10.1016/j.colsurfb.2024.113988. Epub 2024 May 23.
8
Recent Advances in the Fabrication and Performance Optimization of Polyvinyl Alcohol Based Vascular Grafts.基于聚乙烯醇的血管移植物的制备及性能优化的最新进展。
Macromol Biosci. 2024 Sep;24(9):e2400093. doi: 10.1002/mabi.202400093. Epub 2024 Jun 3.
9
Transformation of metallo-elastomer grafts in a carotid artery interposition model over a year.金属弹性体移植物在颈动脉旁路模型中一年多的转化。
Biomaterials. 2024 Sep;309:122598. doi: 10.1016/j.biomaterials.2024.122598. Epub 2024 Apr 26.
10
Development of 3D printed electrospun vascular graft loaded with tetramethylpyrazine for reducing thrombosis and restraining aneurysmal dilatation.负载川芎嗪的3D打印电纺血管移植物的研制,用于减少血栓形成和抑制动脉瘤扩张。
Burns Trauma. 2024 Apr 8;12:tkae008. doi: 10.1093/burnst/tkae008. eCollection 2024.